TARGETING THE HSP40/HSP70 MOLECULAR CHAPERONE AXIS AS A NOVEL TREATMENT STRATEGY FOR CASTRATE-RESISTANT PROSTATE CANCER
$561,864FY2016Department of the ArmyDOD
Regents Of The University Of California, San Francisco, The
Regents Of The University Of California, San Francisco, The